Skip to search formSkip to main contentSkip to account menu

FTY-720

Known as: FTY 720, FTY720 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
FTY720 (fingolimod; 2-amino-2[2-(4-octylphenyl)ethyl]-1,3-propanediol, Novartis) is the prototype of a new generation of… 
Highly Cited
2004
Highly Cited
2004
Our aim was to study the anticancer effect of the novel immunomodulator FTY720 in vitro and in vivo by investigation of cell… 
Highly Cited
2002
Highly Cited
2002
Despite the high frequency of prostate cancer, therapeutic options for advanced disease are limited to chemotherapy, radiation or… 
Highly Cited
1999
Highly Cited
1999
We previously reported that FTY720, a metabolite from Isaria sinclairii, induced some cancer cells to undergo apoptosis, and that… 
Highly Cited
1998
Highly Cited
1998
BACKGROUND We examined the ability of FTY720, a novel immunosuppressant that prolongs the survival of allografts in experimental… 
Highly Cited
1996
Highly Cited
1996
FTY720 is a unique immunosuppressive drug produced by modification of a metabolite from Isaria sinclairii. In vitro treatment of…